1. Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana
- Author
-
Julia Ngidi, Mosepele Mosepele, T Mphoyakgosi, Mark W Tenforde, Bornapate Nkomo, Kwana Lechiile, M Tau, Richard J. Hayes, Charles Muthoga, Fredah Mulenga, Madisa Mine, Joseph N Jarvis, Tshepo B Leeme, and Dinah Ramaabya
- Subjects
0301 basic medicine ,Adult ,Male ,medicine.medical_specialty ,Anti-HIV Agents ,Population ,HIV Infections ,Logistic regression ,Article ,03 medical and health sciences ,0302 clinical medicine ,Acquired immunodeficiency syndrome (AIDS) ,Internal medicine ,Antiretroviral Therapy, Highly Active ,medicine ,Humans ,Pharmacology (medical) ,030212 general & internal medicine ,education ,education.field_of_study ,Botswana ,business.industry ,Health Policy ,Routine laboratory ,virus diseases ,Odds ratio ,Middle Aged ,Viral Load ,medicine.disease ,030112 virology ,Antiretroviral therapy ,Confidence interval ,CD4 Lymphocyte Count ,Infectious Diseases ,Female ,business ,Viral load - Abstract
OBJECTIVES National guidelines in Botswana recommend baseline CD4 count measurement and both CD4 and HIV viral load (VL) monitoring post-antiretroviral therapy (ART) initiation. We evaluated the utility of CD4 count measurement in Botswana in the era of universal ART. METHODS CD4 and VL data were analysed for HIV-infected adults undergoing CD4 count measurement in 2015-2017 at the Botswana Harvard HIV-Reference Laboratory. We determined (1) the proportion of individuals with advanced HIV disease (CD4 count
- Published
- 2020